N Lawrence Edwards

Summary

Affiliation: University of Florida
Country: USA

Publications

  1. ncbi The role of hyperuricemia and gout in kidney and cardiovascular disease
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, 32610 0221, USA
    Cleve Clin J Med 75:S13-6. 2008
  2. ncbi Quality of care in patients with gout: why is management suboptimal and what can be done about it?
    N Lawrence Edwards
    Division of Rheumatology, University of Florida, 1600 Southwest Archer Road, Room 4102, Gainesville, FL 32610 0277, USA
    Curr Rheumatol Rep 13:154-9. 2011
  3. ncbi Febuxostat: a new treatment for hyperuricaemia in gout
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, FL 32610, USA
    Rheumatology (Oxford) 48:ii15-ii19. 2009
  4. ncbi The role of hyperuricemia in vascular disorders
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, 32610 0221, USA
    Curr Opin Rheumatol 21:132-7. 2009
  5. ncbi Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, Florida, USA
    Am J Med 119:S29-31. 2006
  6. ncbi Patient-reported outcomes in chronic gout: a report from OMERACT 10
    Jasvinder A Singh
    Medicine Service, Birmingham Veterans Affairs VA Medical Center and Division of Rheumatology, Department of Medicine, University of Alabama, Birmingham, AL 35294, USA
    J Rheumatol 38:1452-7. 2011
  7. ncbi Pain management in gout
    Brian S Kirby
    Curr Pain Headache Rep 12:418-22. 2008
  8. ncbi Treatment of osteoarthritis
    Elena V Barnes
    Division of Rheumatology, Department of Medicine, University of Florida, Gainesville 32610, USA
    South Med J 98:205-9. 2005
  9. ncbi Case 6: maintenance therapy for simple intermittent gout
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, Florida, USA
    Am J Med 119:S20-2. 2006
  10. ncbi Outcome evaluations in gout
    H Ralph Schumacher
    Division of Rheumatology, University of Pennsylvania School of Medicine, and Veterans Affairs Medical Center, Philadelphia, Pennsylvania 19104, USA
    J Rheumatol 34:1381-5. 2007

Detail Information

Publications11

  1. ncbi The role of hyperuricemia and gout in kidney and cardiovascular disease
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, 32610 0221, USA
    Cleve Clin J Med 75:S13-6. 2008
    ..Additional animal studies and recent epidemiologic findings have provided further evidence that soluble urate is a risk factor for nonarticular disease...
  2. ncbi Quality of care in patients with gout: why is management suboptimal and what can be done about it?
    N Lawrence Edwards
    Division of Rheumatology, University of Florida, 1600 Southwest Archer Road, Room 4102, Gainesville, FL 32610 0277, USA
    Curr Rheumatol Rep 13:154-9. 2011
    ..Widespread education about evidence-based diagnostic and treatment guidelines is desperately needed...
  3. ncbi Febuxostat: a new treatment for hyperuricaemia in gout
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, FL 32610, USA
    Rheumatology (Oxford) 48:ii15-ii19. 2009
    ..In conclusion, febuxostat is more effective than allopurinol 300 mg daily in reducing sUA levels <6 mg/dl (360 mumol/l), the target recommended by EULAR, and offers a new option for the long-term treatment of gout...
  4. ncbi The role of hyperuricemia in vascular disorders
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, 32610 0221, USA
    Curr Opin Rheumatol 21:132-7. 2009
    ..Others have viewed it as an important antioxidant. These opinions have given way to strong epidemiologic evidence that uric acid elevation may damage endothelial cells and cause significant medical problems...
  5. ncbi Case 9: initiation of urate-lowering therapy for advanced gout complicated by chronic renal insufficiency
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, Florida, USA
    Am J Med 119:S29-31. 2006
  6. ncbi Patient-reported outcomes in chronic gout: a report from OMERACT 10
    Jasvinder A Singh
    Medicine Service, Birmingham Veterans Affairs VA Medical Center and Division of Rheumatology, Department of Medicine, University of Alabama, Birmingham, AL 35294, USA
    J Rheumatol 38:1452-7. 2011
    ..To summarize the endorsement of measures of patient-reported outcome (PRO) domains in chronic gout at the 2010 Outcome Measures in Rheumatology Meeting (OMERACT 10)...
  7. ncbi Pain management in gout
    Brian S Kirby
    Curr Pain Headache Rep 12:418-22. 2008
    ..This article addresses the epidemiology, inflammatory pathophysiology, pain management techniques (including recent advances), and treatment of the underlying disease itself...
  8. ncbi Treatment of osteoarthritis
    Elena V Barnes
    Division of Rheumatology, Department of Medicine, University of Florida, Gainesville 32610, USA
    South Med J 98:205-9. 2005
    ..Presently, there are no proven structure/disease-modifying interventions and therefore current therapy is aimed to symptom relief and rehabilitation...
  9. ncbi Case 6: maintenance therapy for simple intermittent gout
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, Florida, USA
    Am J Med 119:S20-2. 2006
  10. ncbi Outcome evaluations in gout
    H Ralph Schumacher
    Division of Rheumatology, University of Pennsylvania School of Medicine, and Veterans Affairs Medical Center, Philadelphia, Pennsylvania 19104, USA
    J Rheumatol 34:1381-5. 2007
    ..Final validation of these outcomes has not yet been achieved. In summary, the unique problems of evaluating outcomes in gout are finally being addressed. While no measures are available for use yet, an agenda has been developed...
  11. ncbi Case 7: differential diagnosis of advanced gout
    N Lawrence Edwards
    Department of Medicine, University of Florida, Gainesville, Florida, USA
    Am J Med 119:S23-4. 2006